levodopa has been researched along with Delirium of Mixed Origin in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (33.33) | 18.7374 |
| 1990's | 5 (33.33) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, N; Choudhury, ME; Doi, T; Hisai, M; Kubo, M; Matsuura, T; Mikami, K; Nagai, M; Nishihara, T; Nishikawa, Y; Tanaka, J; Yajima, C; Yamagishi, S; Yamamoto, H; Yano, H; Yorozuya, T | 1 |
| Daud, DB; McDonald, C | 1 |
| Inoue, M; Inoue, Y; Kishimoto, T; Kiuchi, K; Kosaka, J; Morikawa, M; Norimoto, K | 1 |
| Bang, OY; Joo, US; Lee, PH; Seo, CH | 1 |
| Bleda, MJ; Serrano-Dueñas, M | 1 |
| Danielczyk, W | 1 |
| Coignet, A; de Recondo, J; Rondot, P; Ziegler, M | 1 |
| O'Keeffe, ST | 1 |
| Hirai, S; Kondo, T; Mizuno, Y; Mori, H; Suda, K; Tanabe, K; Yokochi, F | 1 |
| Camicioli, R; Ganzini, L; Young, BK | 1 |
| Grossberg, GT; Nymeyer, L | 1 |
| Postma, JU; Van Tilburg, W | 1 |
| Feigenson, JS; Goodell, H; Loranger, AW; McDowell, FH; Sweet, RD | 1 |
| Manji, HK; Potter, WZ; Rudorfer, MV | 1 |
| Feldman, RD; Pearlman, CA; Sax, DS | 1 |
2 review(s) available for levodopa and Delirium of Mixed Origin
| Article | Year |
|---|---|
Medical and surgical care for patients with Parkinson's disease.
Topics: Antiparkinson Agents; Catechol O-Methyltransferase Inhibitors; Constipation; Delirium; Dizziness; Dopamine Agonists; Hospitalization; Humans; Levodopa; Mobility Limitation; Monoamine Oxidase Inhibitors; Pain; Parkinson Disease | 2018 |
Neuropsychiatric adverse effects of antiparkinsonian drugs. Characteristics, evaluation and treatment.
Topics: Aging; Akathisia, Drug-Induced; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Cholinergic Antagonists; Delirium; Dementia; Depression; Dopamine Agonists; Electroconvulsive Therapy; Humans; Levodopa; Memantine; Monoamine Oxidase Inhibitors; Psychoses, Substance-Induced; Risk Factors; Serotonin Antagonists | 1997 |
1 trial(s) available for levodopa and Delirium of Mixed Origin
| Article | Year |
|---|---|
Mental symptoms in Parkinson's disease during chronic treatment with levodopa.
Topics: Adult; Aged; Delirium; Dementia; Female; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease; Parkinson Disease, Postencephalitic; Tryptophan | 1976 |
12 other study(ies) available for levodopa and Delirium of Mixed Origin
| Article | Year |
|---|---|
Anti-inflammatory effects of dopamine on microglia and a D1 receptor agonist ameliorates neuroinflammation of the brain in a rat delirium model.
Topics: Animals; Anti-Inflammatory Agents; Brain; Delirium; Dopamine; Levodopa; Lipopolysaccharides; Male; Microglia; Neuroinflammatory Diseases; Rats; Rats, Wistar; Receptors, Dopamine D1; Tumor Necrosis Factor-alpha | 2023 |
Parkinsonism with multiple cysts in the bilateral striata.
Topics: 3-Iodobenzylguanidine; Aged; Antiparkinson Agents; Antipsychotic Agents; Brain Ischemia; Delirium; Delusions; Diagnosis, Differential; Dibenzothiazepines; Dominance, Cerebral; Drug Therapy, Combination; Encephalomalacia; Hallucinations; Humans; Levodopa; Magnetic Resonance Imaging; Male; Neostriatum; Neurologic Examination; Organophosphate Poisoning; Parkinsonian Disorders; Psychoses, Substance-Induced; Quetiapine Fumarate; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2011 |
Basal ganglia hyperperfusion in a patient with systemic lupus erythematosus-related parkinsonism.
Topics: Adult; Antiparkinson Agents; Basal Ganglia; Delirium; Epilepsy, Tonic-Clonic; Female; Hallucinations; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Levodopa; Lupus Erythematosus, Systemic; Parkinson Disease, Secondary; Prednisolone; Tomography, Emission-Computed, Single-Photon | 2004 |
Delirium in Parkinson's disease patients. a five-year follow-up study.
Topics: Aged; Analysis of Variance; Antiparkinson Agents; Case-Control Studies; Delirium; Dementia; Female; Follow-Up Studies; Humans; Levodopa; Male; Neuropsychological Tests; Parkinson Disease; Prospective Studies; Psychiatric Status Rating Scales; Regression Analysis; Risk Factors; Survival Analysis | 2005 |
Pharmacotoxic psychoses in patients with neurological disorders in old age.
Topics: Aged; Antidepressive Agents; Antipsychotic Agents; Brain Diseases; Delirium; Digitalis Glycosides; Diuretics; Humans; Levodopa; Middle Aged; Syndrome | 1984 |
Mental disorders in Parkinson's disease after treatment with L-DOPA.
Topics: Aged; Anxiety Disorders; Confusion; Delirium; Dementia; Depressive Disorder; Female; Hallucinations; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease | 1984 |
Delusions of infestation during delirium in a patient with restless legs syndrome.
Topics: Aged; Carbidopa; Delirium; Delusions; Female; Humans; Levodopa; Pneumonia; Restless Legs Syndrome; Thioridazine | 1995 |
[A 75-year-old man with parkinsonism and delirium].
Topics: Aged; Delirium; Fever; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome; Parkinson Disease; Substantia Nigra | 1994 |
Delirium in a 75-year-old woman receiving ECT and levodopa.
Topics: Aged; Delirium; Electroconvulsive Therapy; Female; Humans; Levodopa; Parkinson Disease | 1997 |
Visual hallucinations and delirium during treatment with amantadine (Symmetrel).
Topics: Aged; Amantadine; Benztropine; Biperiden; Delirium; Drug Eruptions; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Orphenadrine; Parkinson Disease | 1975 |
ECT and delirium in Parkinson's disease.
Topics: Carbidopa; Combined Modality Therapy; Delirium; Depressive Disorder; Drug Combinations; Electroconvulsive Therapy; Humans; Levodopa; Parkinson Disease | 1992 |
Psychiatric aspects of L-dopa therapy of Parkinson's disease.
Topics: Adult; Aged; Delirium; Depression; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced | 1972 |